Interferon-α differentially rescues CD4 and CD8 T cells from apoptosis in HIV infection
- 26 June 2006
- journal article
- basic science
- Published by Wolters Kluwer Health in AIDS
- Vol. 20 (10) , 1379-1389
- https://doi.org/10.1097/01.aids.0000233571.51899.ab
Abstract
Objective: To examine the effects of interferon-α (IFN-α) on T cell survival and activation in HIV infection. Design: The effects of IFN-α on spontaneous apoptosis and CD38 expression among T cell subsets were determined in vitro and studied in relation to CD4 cell counts, plasma HIV RNA levels and the age of the subjects. Methods: Peripheral blood mononuclear cells from 48 HIV-infected persons and 17 healthy donors were incubated in vitro overnight with or without the addition of IFN-α. Percentages of apoptotic cells (positive for annexin V) and CD38 cells were determined among T cell subsets. Results: IFN-α inhibited spontaneous apoptosis of CD4 and CD8 T lymphocytes. This protective activity was impaired in CD4 T cells from HIV-infected persons. The reduced protection of IFN-α among CD4 cells from HIV-infected persons was not related to the percentages of activated (CD38 or CD45RO+CD38+) cells. Surprisingly, IFN-α induced CD38 expression among CD8 T cells from HIV-infected persons, and the magnitude of this effect was directly related to circulating CD4 T cell count. The CD8 T cell subset that expressed CD38 in response to IFN-α was defined as CD28 negative, CD62 ligand (CD62L) intermediate/negative. Conclusions: Heightened expression of IFN-α in HIV infection may contribute to the phenotypic activation state that characterizes chronic infection while a diminished responsiveness of CD4 T cells to the protective effect of this cytokine may contribute to differential survival of CD4 and CD8 T cells in HIV disease.Keywords
This publication has 51 references indexed in Scilit:
- Impaired Monocyte Maturation in Response to CpG Oligodeoxynucleotide Is Related to Viral RNA Levels in Human Immunodeficiency Virus Disease and Is at Least Partially Mediated by Deficiencies in Alpha/Beta Interferon Responsiveness and ProductionJournal of Virology, 2005
- Decreased Interferon-α Production in HIV-Infected Patients Correlates with Numerical and Functional Deficiencies in Circulating Type 2 Dendritic Cell PrecursorsClinical Immunology, 2001
- Early control of HIV replication in primary HIV-1 infection treated with antiretroviral drugs and pegylated IFNα: results from the Primoferon A (ANRS 086) StudyAIDS, 2001
- A Randomized Trial of Interferon alpha Therapy for HIV Type 1 InfectionAIDS Research and Human Retroviruses, 2000
- Type I Interferon Is a Powerful Inhibitor of in Vivo HIV-1 Infection and Preserves Human CD4+ T Cells from Virus-Induced Depletion in SCID Mice Transplanted with Human CellsVirology, 1999
- Inhibition of T cell apoptosis by IFN-β rapidly reverses nuclear translocation of protein kinase C-δEuropean Journal of Immunology, 1999
- Phase I Trial of Interferon Alfa-n3 in Early-Stage Human Immunodeficiency Virus Type 1 Disease: Evidence for Drug Safety, Tolerance, and Antiviral ActivityThe Journal of Infectious Diseases, 1996
- Regulation and Characterization of the Interferon-α Present in Patients with Advanced Human Immunodeficiency Virus Type 1 DiseaseJournal of Interferon & Cytokine Research, 1996
- Interferon-regulated viral replication in chronically HIV1-infected promonocytic U937 cellsResearch in Virology, 1991
- Downregulation of interferon alpha but not gamma receptor expression in vivo in the acquired immunodeficiency syndrome.Journal of Clinical Investigation, 1988